Home LiteratureArticle Details
PMID: 22822247 Published · ppublish English Journal Article

Semiparametric methods for evaluating risk prediction markers in case-control studies.

Biometrika ·Vol. 96 ·No. 4 ·2009-12-00 ·Pages 991-997

Huang Y, Pepe MS

Abstract

The performance of a well-calibrated risk model for a binary disease outcome can be characterized by the population distribution of risk and displayed with the predictiveness curve. Better performance is characterized by a wider distribution of risk, since this corresponds to better risk stratification in the sense that more subjects are identified at low and high risk for the disease outcome. Although methods have been developed to estimate predictiveness curves from cohort studies, most studies to evaluate novel risk prediction markers employ case-control designs. Here we develop semiparametric methods that accommodate case-control data. The semiparametric methods are flexible, and naturally generalize methods previously developed for cohort data. Applications to prostate cancer risk prediction markers illustrate the methods.

Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Huang Ying
Fred Hutchinson Cancer Research Center, Public Health Sciences, 1100 Fairview Avenue N., Seattle, Washington 98109-1024 , U.S.A. yhuang@fhcrc.org mspepe@u.washington.edu.
Pepe Margaret Sullivan
References (10)
10 references, click to expand
  1. Smoothing reference centile curves: the LMS method and penalized likelihood.
    Stat Med. 1992 Jul;11(10):1305-19 PMID: 1518992
  2. Integrating the predictiveness of a marker with its performance as a classifier.
    Am J Epidemiol. 2008 Feb 1;167(3):362-8 PMID: 17982157
  3. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial.
    J Natl Cancer Inst. 2006 Apr 19;98(8):529-34 PMID: 16622122
  4. Roadmap for developing and validating therapeutically relevant genomic classifiers.
    J Clin Oncol. 2005 Oct 10;23(29):7332-41 PMID: 16145063
  5. Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design.
    J Natl Cancer Inst. 2008 Oct 15;100(20):1432-8 PMID: 18840817
  6. Phases of biomarker development for early detection of cancer.
    J Natl Cancer Inst. 2001 Jul 18;93(14):1054-61 PMID: 11459866
  7. How to improve reliability and efficiency of research about molecular markers: roles of phases, guidelines, and study design.
    J Clin Epidemiol. 2007 Dec;60(12):1205-19 PMID: 17998073
  8. Evaluating the predictiveness of a continuous marker.
    Biometrics. 2007 Dec;63(4):1181-8 PMID: 17489968
  9. A parametric ROC model-based approach for evaluating the predictiveness of continuous markers in case-control studies.
    Biometrics. 2009 Dec;65(4):1133-44 PMID: 19459841
  10. Markers for early detection of cancer: statistical guidelines for nested case-control studies.
    BMC Med Res Methodol. 2002;2:4 PMID: 11914137
Article Info
Journal
Biometrika
Abbr.
Biometrika
ISSN
0006-3444
Published
2009-12-00
Epub
2009-00-12
Pages
991-997
Language
English
Region
England
NLM ID
0413661
PMCID
PMC3372083
Grants
NCI NIH HHS · R01 CA129934 · United States
NIGMS NIH HHS · R01 GM054438 · United States
NCI NIH HHS · U01 CA086368 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com